Tanezumab in Osteoarthritis of the Hip or Knee (2)

Completed · Phase 3 · Has a placebo group

Conditions studied: Osteoarthritis

In brief

Test the efficacy and safety of 2 doses of tanezumab compared with naproxen and placebo in patients with osteoarthritis

Key facts

Study ID
NCT00863304
Run by
Pfizer
People needed
849
Starts
2009-06-09
Expected to finish
2010-08-16
Last updated by the study team
2021-05-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.